- $58.35bn
- $57.34bn
- $2.31bn
U.S. RESEARCH ROUNDUP- Coinbase Global, Meta, Union Pacific
Brief: Natera Says Court Ordered Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
U.S. RESEARCH ROUNDUP- Alight, Mastercard, Visa
U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone
U.S. STOCKS ON THE MOVE-Synchrony, Grindr, Blend Labs
U.S. STOCKS ON THE MOVE-Doximity, Expedia, Nikola
Natera falls after delaying study data for colorectal cancer test
Natera Inc reports results for the quarter ended in June - Earnings Summary
Brief: Natera Q2 Net Income USD -37.5 Million
Natera Inc expected to post a loss of 69 cents a share - Earnings Preview
Natera Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Natera To Redeem $287.5 Million Convertible Senior Notes Due 2027
Brief: Natera Announces Decipher A Phase Ii, Single-Arm Adjuvant Trial
U.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
U.S. STOCKS ON THE MOVE-H&R Block, McDonald, Groupon
U.S. STOCKS ON THE MOVE-Victoria's Secret, Mettler-Toledo, Dropbox
Natera leaps after Q1 beat-and-raise report
U.S. RESEARCH ROUNDUP- Corpay, Epam Systems, MKS Instruments